Showing results (731-740 of 2,811) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|February 18, 2022
An update on phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a review of safety profilesHiroaki Ogata, Akiko Takeshima, Hidetoshi ItoExpert Opinion on Drug Safety|February 23, 2022
Drug-induced Stevens-Johnson syndrome: a disproportionality analysis from the pharmacovigilance database of the World Health OrganizationYi Zheng, Wenli Zhou, Xiaojing Guo, et al.Expert Opinion on Drug Safety|November 1, 2021
Improving the risk-to-benefit ratio of inhaled corticosteroids through delivery and dose: current progress and future directionsPiotr Damiański, Grzegorz Kardas, Michał Panek, et al.Expert Opinion on Drug Safety|January 31, 2022
Compared of efficacy and safety of high-dose donepezil vs standard-dose donepezil among elderly patients with Alzheimer's disease: a systematic review and meta-analysisHecheng Wang, Yu Zong, Yanshuo Han, et al.Expert Opinion on Drug Safety|March 2, 2022
Opioid-related adverse drug events in surgical patients: risk factors and association with clinical outcomesChin Hang Yiu, Danijela Gnjidic, Asad Patanwala, et al.Expert Opinion on Drug Safety|September 23, 2021
Breast cancer treatment-related cardiovascular disturbances: advocacy for a watchful attitude in this never-ending storyCharlène Rivier, Benoite Mery, Elise Rowinski, et al.Expert Opinion on Drug Safety|May 7, 2019
Role of healthcare databases and registries for surveillance of orphan drugs in the real-world setting: the Italian case studySalvatore Crisafulli, Janet Sultana, Ylenia Ingrasciotta, et al.Expert Opinion on Drug Safety|March 2, 2022
Hepatic safety of the antifungal triazole agent posaconazole: characterization of adverse event reports in a manufacturer's safety databaseRose O'Flynn, Yun-Ping Zhou, Hetty Waskin, et al.Expert Opinion on Drug Safety|December 17, 2022
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledgeAngelo Ruggiero, Elisa Camela, Luca Potestio, et al.Expert Opinion on Drug Safety|May 5, 2015
Selective estrogen receptor modulators in clinical practice: a safety overviewAmanda J Ellis, Vicky M Hendrick, Robert Williams, et al.Pageof 282